Potential mechanisms of vaccine-induced thrombosis
M Marietta, V Coluccio, M Luppi - European Journal of Internal Medicine, 2022 - Elsevier
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare syndrome
characterized by high-titer anti-platelet factor 4 (PF4) antibodies, thrombocytopenia and …
characterized by high-titer anti-platelet factor 4 (PF4) antibodies, thrombocytopenia and …
[HTML][HTML] How to approach acute thrombosis and thrombocytopenia
J Schofield, CH Toh - Clinical Medicine, 2023 - rcpjournals.org
Acute thrombosis and thrombocytopenia pose challenges to the clinician.
Thrombocytopenia is naturally viewed as a risk factor for bleeding, and an association with …
Thrombocytopenia is naturally viewed as a risk factor for bleeding, and an association with …
[HTML][HTML] Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis
M Simpson, A Narwal, E West, J Martin… - Journal of Thrombosis …, 2023 - Elsevier
Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare
syndrome associated with adenoviral vector vaccines for COVID-19. The syndrome is …
syndrome associated with adenoviral vector vaccines for COVID-19. The syndrome is …
[HTML][HTML] Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia
ST Abrams, M Du, RJ Shaw, C Johnson… - Journal of Thrombosis …, 2024 - Elsevier
Background Adenoviral vector-based COVID-19 vaccine-induced immune thrombotic
thrombocytopenia (VITT) is rare but carries significant risks of mortality and long-term …
thrombocytopenia (VITT) is rare but carries significant risks of mortality and long-term …
[HTML][HTML] Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
VAS Dabbiru, L Müller, L Schönborn… - Journal of Clinical …, 2023 - mdpi.com
An effective worldwide vaccination campaign started and is still being carried out in the face
of the coronavirus disease 2019 (COVID-19) pandemic. While vaccines are great tools to …
of the coronavirus disease 2019 (COVID-19) pandemic. While vaccines are great tools to …
Blood coagulation and beyond: position paper from the Fourth Maastricht Consensus Conference on Thrombosis
AC Akbulut, RA Arisz, CC Baaten… - Thrombosis and …, 2023 - thieme-connect.com
The Fourth Maastricht Consensus Conference on Thrombosis included the following
themes. Theme 1: The “coagulome” as a critical driver of cardiovascular disease. Blood …
themes. Theme 1: The “coagulome” as a critical driver of cardiovascular disease. Blood …
[HTML][HTML] Health means more than just healthcare
A Emmanuel - Clinical Medicine, 2022 - ncbi.nlm.nih.gov
The relevance of a medical journal to its readership depends on more than just presenting
updates on clinical topics. It is also important to lean into those aspects of public policy that …
updates on clinical topics. It is also important to lean into those aspects of public policy that …
[PDF][PDF] COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia Leading to Stroke: An Extremely Rare but Possible Condition
M Muhammad, SK Loong, S AbuBakar - researchgate.net
Abstract Coronavirus disease 2019 (COVID-19) vaccines remain the safest and most
effective strategy against the COVID-19 pandemic. However, clinicians must be aware of …
effective strategy against the COVID-19 pandemic. However, clinicians must be aware of …